Mepro-Aspirin

Mepro-Aspirin Brand names, Mepro-Aspirin Analogs

Mepro-Aspirin Brand Names Mixture

No information avaliable

Mepro-Aspirin Chemical_Formula

C₂₀H₂₃NS

Mepro-Aspirin RX_link

No information avaliable

Mepro-Aspirin fda sheet

Mepro-Aspirin msds (material safety sheet)

Mepro-Aspirin Synthesis Reference

No information avaliable

Mepro-Aspirin Molecular Weight

309.469 g/mol

Mepro-Aspirin Melting Point

< 25 ^oC

Mepro-Aspirin H₂O Solubility

Soluble as HCl salt

Mepro-Aspirin State

Liquid

Mepro-Aspirin LogP

5.7

Mepro-Aspirin Dosage Forms

Tablets (oral, 1 mg)

Mepro-Aspirin Indication

Used for the symptomatic treatment of parkinsonism.

Mepro-Aspirin Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Mepro-Aspirin Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Mepro-Aspirin side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Mepro-Aspirin Patient Information

Mepro-Aspirin Organisms Affected

Humans and other mammals